Contact FAQ

Who We Are Our Team

Staff & Good Pharma Scorecard Team

Jennifer E. Miller, PhD

Founder, Bioethics International
and Good Pharma Scorecard
Associate Professor, Yale University School of Medicine

Joseph S. Ross, MD, MHS

Co-Investigator, Good Pharma Scorecard
Professor, Yale School of Medicine

Michelle Mello, JD, PhD

Co-Investigator, Good Pharma Scorecard
Professor, Stanford University

Cary Gross, MD

Co-Investigator, Good Pharma Scorecard
Professor, Yale School of Medicine

Tanvee Varma, MDc

Researcher, Good Pharma Scorecard, Yale School of Medicine

William Pelletiers

Data analyst, Good Pharma Scorecard, Fellow, Yale School of Medicine

Sakinah Carter Suttiratana PhD, MPH, MBA

Co-Investigator, GPS Positive Deviance Study,
Co-Director, Center for Community Engagement and Health Equity, Yale University

Reshma Ramachandran MD, MPP, MHS

Co-Investigator, GPS Positive Deviance Study,
Assistant Professor, Yale School of Medicine

Jason L. Schwartz, PhD

Co-Investigator, GPS Positive Deviance Study,
Associate Professor, Yale School of Public Health

Board of Directors and Advisors

Jennifer E. Miller, PhD

Founder, Bioethics International
Assistant Professor, Yale University School of Medicine

Wilco Faessen

Managing Director, Barclays Capital

Marie-Catherine Letendre, PhD

Department Chair, Marymount International School, Italy

Liam O’Brien, Esq

Managing Partner, McCormick & O’Brien LLP

Stephen M. Sammut, MBA, PhD

Senior Fellow, Health Care Management Wharton School

Marc Wilenzick, Esq

Associate General Counsel, Gilead

Jeremy Abbate*

Publisher, Scientific American

Tanisha Carino*

EVP, Chief Corporate Affairs Officer, Alexion

Doug Dickerson, MBA*

State Director, AARP

Patrick Jordan, MBA, MA*

Chief Administration Officer, Encore, A Quintiles Company

Llew Keltner, MD, PhD*

CEO, EPISTAT
Professor of Bioethics, Columbia University

Leslie J. Levinson, Esq.*

Partner & Co-chair of Transactional Health Law Group, Robinson+Cole

Mark McClellan, MD, PhD*

Former FDA Commissioner and CMS Administrator
Senior Fellow and Director, Health Care Innovation and Value Initiative, Brookings Institution

Mark R. Mercurio, MD, FAAP*

Director, Yale Pediatric Ethics Program
Co-Chair, Yale-New Haven Hospital Ethics Committee
Professor, Yale School of Medicine

Puru Pathak, MS*

Software Engineer, Cloud Computing, Amazon

Mike Rea*

CEO, IDEA Pharma

Briggs W. Morrison, MD*

CEO, Syndax Pharmaceuticals

Lauren Rogge*

Manager, Climate Change and Sustainability, Ernst & Young

Lucy Rose, MBA*

CEO, Lucy Rose and Associates
Former Director, FDA CDER DDMAC

Richard Wilder*

Associate General Counsel, Gates Foundation

Kimberly Sabelko*

Managing Director, Susan G. Komen for the Cure

Rob Scott, MD*

Retired Chief Medical Officer, Abbvie

Bray Patrick-Lake*

Director of Strategic Partnerships at Evidation Health
Patient Representative, PCORnet

Cheryl Pegus, MD*

EVP, Health & Wellness, Walmart
Board Chair, Association of Black Cardiologists
(Advisor on SciAm project)

Jessica Scott, MD*

President, Legacy Health Strategies

Joanne Waldstreicher, MD*

CMO, Johnson & Johnson
Affiliated Faculty, NYU School of Medicine, Division of Medical Ethics

Pierre Theodore, MD''

Vice President, Global Public Health, Johnson & Johnson

David Leventhal''

Senior Director, Enterprise Clinical Trial Data Sharing Lead, Pfizer

''Bioethics think tank member

*Advisory Board

“

No one organization brings forward ethical questions to a level easily understood on a daily basis by clinicians and managers alike than Bioethics International. Finally, a mechanism that operationalizes ethics for the clinician!

Frederick M. Burkle, Jr., MD, MPH, DTM, Professor, Sr. Fellow, Harvard Humanitarian Initiative, Harvard University, Cambridge